ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-pxxxvi.xmlReviewer Page2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-pxxxvi.pdf2026-04-18Reviewer Pagehttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1452.xmlChampions Rising to the Challenge of Ensuring High-Quality Cancer Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1452.pdf2026-04-18Champions Rising to the Challenge of Ensuring High-Quality Cancer Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1449.xmlBehavioral Economics and the Future of Biosimilars2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1449.pdf2026-04-18Behavioral Economics and the Future of Biosimilarshttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-pxxxviii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-pxxxviii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1443.xmlIt's About Time!2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1443.pdf2026-04-18It's About Time!https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-plxiii.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-plxiii.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1476.xmlExternal Validation of Generic and Cancer-Specific Risk Stratification Tools in Patients With Pulmonary Embolism and Active Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1476.pdf2026-04-18External Validation of Generic and Cancer-Specific Risk Stratification Tools in Patients With Pulmonary Embolism and Active Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1465.xmlNCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.20172026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1465.pdf2026-04-18NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1460.xmlEnsuring Patient Safety and Access in Cancer Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1460.pdf2026-04-18Ensuring Patient Safety and Access in Cancer Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1456.xmlPazopanib Sensitivity in a Patient With Breast Cancer and FGFR1 Amplification2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1456.pdf2026-04-18Pazopanib Sensitivity in a Patient With Breast Cancer and FGFR1 Amplificationhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1520.xmlMyeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1520.pdf2026-04-18Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1543.xmlA Patient Risk Model of Chemotherapy-Induced Febrile Neutropenia: Lessons Learned From the ANC Study Group2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1543.pdf2026-04-18A Patient Risk Model of Chemotherapy-Induced Febrile Neutropenia: Lessons Learned From the ANC Study Grouphttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1551.xmlControversies Regarding Use of Myeloid Growth Factors in Leukemia2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1551.pdf2026-04-18Controversies Regarding Use of Myeloid Growth Factors in Leukemiahttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1484.xml KRAS Testing, Tumor Location, and Survival in Patients With Stage IV Colorectal Cancer: SEER 2010–20132026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1484.pdf2026-04-18 KRAS Testing, Tumor Location, and Survival in Patients With Stage IV Colorectal Cancer: SEER 2010–2013https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1509.xmlGeographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part D2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1509.pdf2026-04-18Geographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part Dhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1494.xmlRadiosurgery for Brain Metastases: Changing Practice Patterns and Disparities in the United States2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1494.pdf2026-04-18Radiosurgery for Brain Metastases: Changing Practice Patterns and Disparities in the United Stateshttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1503.xmlPrevalence of Physical Problems Detected by the Distress Thermometer and Problem List in Patients With Myeloproliferative Disorders2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1503.pdf2026-04-18Prevalence of Physical Problems Detected by the Distress Thermometer and Problem List in Patients With Myeloproliferative Disordershttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1559.xmlDisparities in Adjuvant Endocrine Therapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/12/article-p1559.pdf2026-04-18Disparities in Adjuvant Endocrine Therapy